Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1142.60 -63.40 (-5.26%)

51.15% Gain from 52W Low

233.0K NSE+BSE Volume

NSE 16 May, 2025 3:31 PM (IST)

14,011.6

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Rapid Results

Q4FY25 & FY25 Result Announced for Alivus Life Sciences Ltd. See details

Alivus Life Sciences Ltd. News and Updates

Keep track of all breaking news on Alivus Life Sciences Ltd. from all sources in a single place.

Load latest

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

123 Votes:

Buy 75.61%

Sell 13.01%

Hold 11.38%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >